Keep in mind by the time WYY does the year end cc their 1st quarter is complete. First quarter cc should be only 6 weeks or so after the year end call. The CEO should have a good idea of business climate regarding the DHS contract. Share price has been holding steady but needs the cc and positive forecast to take the next move upward.
Are you the scientist? Show us a fraudulent statement please. The dream team for 50 K convinced all of those upgrades? Sub group trails? Really is that the best you have? Ignore the idiots. Yes that would be you.
What is "such sneaky". Boiler room talk? Paid bashers that don't really understand English? Nice job. Ignore the idiot lawsuit posts.
Hopefully you are moving on. We know your opinion-- you cant be long -- so you post daily over and over because you are a short - pushing your view , right or wrong about the sharks that are looking for clients as a lead to start a legal action. Most of these will never materialize and what makes you think if it is fraud that GALE defends them? Lets just place all you idiots on ignore and wait for the cc. Thanks for your opinion -- good bye
I would doubt that a MM is holding lots of shares of a small stock that shot up the way this one did. You don't think you all ready saw your spike in MEET the past week= month? Need earnings and guidance now.
Do you own a lot of biopharma companies? Do they have revenue while they run phase 2 & 3 trails? GALE does have a drug being marketed and will report revenue again this quarter. Companies running trails do not generally operate in the black unless they are large well established drug companies with proven products. Ahn could not give out numbers today with earnings release / cc next monday.
This year may be more of a stock pickers year as far as " performance". (No pum intended)
Earnings after hours on Wednesday you think? I was a bit surprised to see AMOT close up 3 %. Of course that could have been on a 10 share trade. Hope to see some positive guidance regarding business climate and new acquisiton to kick start the share price again. It does get frustrating when one amall trade can move the share price up or down 3 or 4 %.
How can they have preliminary data for a phase 3 trial that is still in a enrollment period? You have the classic pump going--results before the test is started?
KORS message board is starting to get useless, alot like some of the pump and dump boards with constant fighting. 255 K profits and Ascending triangles now blocked with about 4 posters posting the same message. It would be nice to be back to the 3 or 4 posters who make sense here.
I still don't understand UA pe compared to the KORS pe. With the growth numbers how can there not be a pe expansion in KORS? Why is there a "discount " in KORS stock? Are investors looking at fashion line vs a sports product-- one may go out of style but UA will always have their customers? Looking at Coach and what happened to the trend over the years.
We should get a good idea of how the DHS contract is moving along. Share price will be all about the guidance for next couple of quarters. WYY is holding the year end CC 90 days after year end so the first quarter is already coming to an end. It should only be 1 1/2 months until they need to hold the 1st quarter cc. I think if I understand the SEC rules, WYY is now a big enough company that next year they will need to file in 75 days rather than 90 days. I am not sure I believe the .20 cent a share profits next year that some of the posters here are guessing.
Did you say Teva could " buy Galena and keep the drugs they like and sell the rest" ? How many drugs do they currently have? Isn't every thing else in phase 2 or 3 studies other than Abstral. If these drugs were approved years from now I doubt that TEVA would not "like them" .
I doubt there are any legal expenses right now. The companies that want to sue are just a bunch of ambulance chasers looking for a lead client.
Insiders are rarely right when they sell shares. On the other hand the share price may be way ahead of itself since the phase 3 trail will be years before meaningfull numbers are released. The current drug Abstral is a limited market product.
Shares may look a sick shade of green but the share price will not be green today. Time to have someone from the company preannounce the projected sales numbers and give a date for earning/ cc
I think we have seen the upward movement in anticipation of the conference. Low volume but upward since the offering was announced and closed. I don't think they will have any major announcements at the conference. That would not be the place for a meaningfull news discloseure would it?
This is just a nonsense bs post that has appeared on numerous message boards. Does not refer to KORS or any other holding. put on ignore Waiting for the move over 100 again. Coming any day.
I do not think there is a acquisition target. Along with the DHS contract you really think they need a acquisition at this time? Would seem to be too much on the plate , too soon for this size company. I know they indicated the shelf offering was for a acquisition purpose but don't you think they may just be looking at start up expenses that may occur along with debt retirment.
With that out of the way do they now announce their earnings release date? If I am not mistaken the earnings and cc should be set for next week. Not expecting big earnings numbers but a very positive cc.
Funny post. Q went from short to long on what date? Nice story that someone may believe but I doubt it. Cover quick if you get a chance to tomorrow 4 dollars lower. Not likely that it stays down for too long is there? Russia only invades neighbors on occasion.